These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Recent developments in the use of antidepressant and anxiolytic medications. Simeon JG; Ferguson HB Psychiatr Clin North Am; 1985 Dec; 8(4):893-907. PubMed ID: 2867535 [TBL] [Abstract][Full Text] [Related]
24. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder. Cohn JB; Wilcox C J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677 [TBL] [Abstract][Full Text] [Related]
25. Drug treatment of panic disorder--a critical review of controlled clinical trials. Balestrieri M; Ruggeri M; Bellantuono C Psychiatr Dev; 1989; 7(4):337-50. PubMed ID: 2577301 [TBL] [Abstract][Full Text] [Related]
27. Antidepressant drug therapy for bulimia: current status. Pope HG; Hudson JI J Clin Psychiatry; 1986 Jul; 47(7):339-45. PubMed ID: 3087968 [TBL] [Abstract][Full Text] [Related]
28. Atypical antidepressants versus imipramine in the treatment of major depression: a meta-analysis. Workman EA; Short DD J Clin Psychiatry; 1993 Jan; 54(1):5-12. PubMed ID: 8428898 [TBL] [Abstract][Full Text] [Related]
29. Stimulants in the treatment of depression: a critical overview. Satel SL; Nelson JC J Clin Psychiatry; 1989 Jul; 50(7):241-9. PubMed ID: 2567730 [TBL] [Abstract][Full Text] [Related]
30. Differential response patterns to MAO inhibitors and tricyclics. Nies A J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487 [TBL] [Abstract][Full Text] [Related]
31. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression. Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993 [TBL] [Abstract][Full Text] [Related]
32. Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients. Schweizer E; Feighner J; Mandos LA; Rickels K J Clin Psychiatry; 1994 Mar; 55(3):104-8. PubMed ID: 8071246 [TBL] [Abstract][Full Text] [Related]
33. Lessons to be learned from long-term treatment of affective disorders: potential utility in panic disorder. Kupfer DJ J Clin Psychiatry; 1991 Feb; 52 Suppl():12-6; discussion 17. PubMed ID: 1995597 [TBL] [Abstract][Full Text] [Related]
34. New developments in the treatment of depression. Montgomery SA J Clin Psychiatry; 1999; 60 Suppl 14():10-5; discussion 31-5. PubMed ID: 10408420 [TBL] [Abstract][Full Text] [Related]
35. [Value of fluoxetine in obsessive-compulsive disorder in the adult: review of the literature]. Etain B; Bonnet-Perrin E Encephale; 2001; 27(3):280-9. PubMed ID: 11488259 [TBL] [Abstract][Full Text] [Related]
36. Paroxetine treatment of mood and anxiety disorders in children and adolescents. Wagner KD Psychopharmacol Bull; 2003; 37 Suppl 1():167-75. PubMed ID: 14566209 [TBL] [Abstract][Full Text] [Related]
37. Psychopharmacologic validation of atypical depression. Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Tricamo E; Markowitz JS; Klein DF J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483 [TBL] [Abstract][Full Text] [Related]
38. The mousetrap: managing the placebo effect in antidepressant trials. Lakoff A Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352 [No Abstract] [Full Text] [Related]